Cited 0 time in
Dapsone으로 치료된 스테로이드 저항성 손의 호중구성 피부염 1예
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 오의현 | - |
| dc.contributor.author | 천동욱 | - |
| dc.contributor.author | 고주연 | - |
| dc.contributor.author | 노영석 | - |
| dc.contributor.author | 김정은 | - |
| dc.date.accessioned | 2022-07-13T20:02:48Z | - |
| dc.date.available | 2022-07-13T20:02:48Z | - |
| dc.date.issued | 2017-07 | - |
| dc.identifier.issn | 0494-4739 | - |
| dc.identifier.issn | 2713-7627 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/151982 | - |
| dc.format.extent | 3 | - |
| dc.language | 한국어 | - |
| dc.language.iso | KOR | - |
| dc.publisher | 대한피부과학회 | - |
| dc.title | Dapsone으로 치료된 스테로이드 저항성 손의 호중구성 피부염 1예 | - |
| dc.title.alternative | A Case of Steroid-resistant Neutrophilic Dermatosis of the Hands Treated with Dapsone | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.scopusid | 2-s2.0-85041398364 | - |
| dc.identifier.bibliographicCitation | 대한피부과학회지, v.55, no.6, pp 374 - 376 | - |
| dc.citation.title | 대한피부과학회지 | - |
| dc.citation.volume | 55 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 374 | - |
| dc.citation.endPage | 376 | - |
| dc.identifier.kciid | ART002246134 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Dapsone | - |
| dc.subject.keywordAuthor | Neutrophilic dermatosis of the hands | - |
| dc.identifier.url | https://kiss.kstudy.com/thesis/thesis-view.asp?key=3526476 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
